Who’s acquiring who? Virtual care M&A activity in the pharmaceutical industry increased by 100% in Q1 2023
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 6 pharmaceutical deals announced in Q1…
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 6 pharmaceutical deals announced in Q1 2023, worth a total value of $426.2m. The $250m merger of Clearday and Viveon Health Acquisition and 98point6 was the industry’s largest disclosed deal. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on market segments forecast up to 2030. Buy the report here.
In value terms, virtual care-related deal activity increased by 7003% in Q1 2023 compared with the previous quarter’s total of $6m. Related deal volume increased by 100% in Q1 2023 versus the previous quarter and was 500% higher than in Q1 2022.
The top-ranked legal advisors supporting these M&A deals in Q1 2023 were Greenberg Traurig; Morrison Foerster; Sheppard, Mullin, Richter & Hampton with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.
What's Your Reaction?
